IGNIX is the universal launchpad on @XLayerOfficial and we are joining the $5M RWA Liquidity Incentive Program.
We support the launch of any asset with these core features:
✅AI Agents: The first to launch agent tokens with verified revenue
✅RWA Memes: Anchor momentum to real-world utility.
✅The Asset Factory: Flexible models and custom taxes.
✅Permanent Liquidity Locking
Every token launched on IGNIX is eligible to participate in the $5M RWA Liquidity Incentive Program.
Launch soon. Your conviction, our ignition.
🧬 BREAKING: Our CRISPR-GPT paper is out TODAY in Nature Biomedical Engineering @natBME !
🤯 We built an AI agent that turns ANYONE into a gene-editing expert in 1 DAY instead of months. An undergrad with ZERO experience achieved 90%+ editing efficiency on their FIRST attempt.
🧵 Here's how we're building expert AI agents for cutting-edge biotechnology:
🎯 The Problem: CRISPR is revolutionary but requires PhD-level expertise, it can take weeks to learn, adopt, and design, analyze a CRISPR experiment for R&D or making life-saving medicine. Even Pro scientists can make small mistakes (e.g. typos in guideRNA or cloning design) that cost months to find out, slowing us down.
💡 Our Solution: CRISPR-GPT - an AI co-pilot from @Stanford@Princeton@GoogleDeepMind that guides you through EVERY step via simple conversation
🔬 Real Results:
-Novice researcher: ~90% editing on 1st go
-Training time: Months → 1 day
-100% success rate in our trials
-Even experts save days/weeks on data analysis & troubleshooting
🤖 How it works: Our multi-agent system handles: CRISPR system and delivery method selection, guideRNA design, Protocol generation, Real-time troubleshooting, Data analysis, and beyond. All through natural language! No coding, no complex software.
📊 We benchmarked it extensively:
-288 evaluation scenarios/cases
-Outperformed GPT-4o on ALL gene editing tasks
-Trained on 11 years of expert discussions
-Covers knockout, base-editing, prime-editing & epigenetic editing
🌍 Why this matters:
-Every lab can now use CRISPR with an AI system distilling expert knowledge and skills.
-Every student can learn faster.
-Every researcher can tackle bigger challenges without worrying about small mistakes.
-Customized CRISPR design can be automated based on your need and the context of R&D workflow.
-Agentic AI ensure safety, privacy, and responsibility
-We're not just automating gene editing - we're using AI to power scientists to cure diseases.
🚀 Try it yourself! Beta access available at: https://t.co/CFQzrdVVPW
Paper: https://t.co/WOgmAjg1Ed
Code: https://t.co/UnPKrxyJuW
Benchmark (companion work, Genome-bench): https://t.co/LIooAXj2op
Co-first and key authors: @YuanhaoQ@KaixuanHuang1@MingYin_0312
PIs: @lecong@MengdiWang10
Key collaborators: @Rbaltman@denny_zhou
The future of biology and science is conversational. The future is now. @natBME@NaturePortfolio
#CRISPR #AI #GeneEditing #Biotech #Science #AISafety
Exit waterfall analysis just got a lot easier with Standard Metrics’ AI Analyst. Work that used to take hours is now just a prompt away. 💧
We're now going deeper by adding more structured financing terms to our data model, including liquidation preferences with participation type and seniority. That means investors will be able to model increasingly sophisticated investments without heavy prompting.
"What are our returns if the company sells for $500M?" should be a quick question, not a lengthy spreadsheet exercise. No complex models, digging through documents, or hopping between platforms to get the answer you’re looking for.
See what else our AI Analyst at @metrics_co can do for your firm → https://t.co/dByYKsV8al